3C-LIKE PROTEINASE (SARS-COV-2)

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 06:14:31 GMT 2025` Edited by `admin` on `Wed Apr 02 06:14:31 GMT 2025`
Protein Type	VIRAL NON-STRUCTURAL PROTEIN
Protein Sub Type
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	0T3KCZ2856
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

3C-LIKE PROTEINASE (SARS-COV-2)

Common Name

English

3C-LIKE CYSTEINE PROTEINASE (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2)

Preferred Name

English

3CL-PRO (SARS-COV-2, WUHAN-HU-1)

Common Name

English

CoV-2 3CLpro

Common Name

English

NSP5 (SARS-COV-2, WUHAN-HU-1)

Common Name

English

NON-STRUCTURAL PROTEIN 5 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2)

Common Name

English

3CLPRO (SARS-COV-2, WUHAN-HU-1)

Common Name

English

Code System Code Type Description

FDA UNII

0T3KCZ2856

Created by admin on Wed Apr 02 06:14:31 GMT 2025 , Edited by admin on Wed Apr 02 06:14:31 GMT 2025

PRIMARY

Related Record Type Details


					B5R5IQ1D64

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					7R9A5P7H32

INHIBITOR -> TARGET

Comments:

Protease activity inhibited via a reversible covalent mechanism involving reaction of the cyano group with the catalytic Cys145 residue

Qualification:

Ki

Amount:


					5C2EJ8H89M

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					R4QFU2UR3K

INHIBITOR -> TARGET

Interaction Type:

IRREVERSIBLE INHIBITOR

Qualification:

IC50

Amount:


					RGE5K1Q5QW

WEAK INHIBITOR->TARGET

Amount:


					B5R5IQ1D64

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					E749PN51FV

ORF1AB POLYPROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2)

PARENT->CLEAVED PROTEIN

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL